| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Haartman Institute, Department of Virology, University of Helsinki, FIN-00014 Helsinki, Finland
p21Waf1/Cip1 (hereafter referred to as p21) is up-regulated in differentiating and DNA-damaged cells, but it is also up-regulated by serum and growth factors. We show here that fibroblast growth factor-2 (FGF-2), platelet-derived growth factor (PDGF), and transforming growth factor-ß1 (TGF-ß1) all induce p21 expression in mouse fibroblasts, but with markedly different kinetics. We link their effect on p21 to Ras and mitogen-activated protein kinase kinase-1(/2) [MEK1(/2)]-regulated pathways using either a specific MEK1(/2) inhibitor (PD 098059) or cells expressing conditionally activated Ras or dominant negative Ras. We demonstrate that p21 induction by PDGF and TGF-ß1 requires MEK1(/2) and, additionally, that the TGF-ß1 effect on p21 depends on Ras, whereas the PDGF effect does not. In contrast, FGF-2 regulation of p21 is largely independent of MEK and Ras. However, PD 098059 efficiently inhibited S-phase entry of quiescent cells induced by either FGF-2 or PDGF, suggesting separate signaling pathways for FGF-2 in induction of p21 and in S-phase entry. The results suggest different but partly overlapping signaling pathways in growth factor regulation of p21.
This article has been cited by other articles:
![]() |
F. S. Santiago, H. Ishii, S. Shafi, R. Khurana, P. Kanellakis, R. Bhindi, M. J. Ramirez, A. Bobik, J. F. Martin, C. N. Chesterman, et al. Yin Yang-1 Inhibits Vascular Smooth Muscle Cell Growth and Intimal Thickening by Repressing p21WAF1/Cip1 Transcription and p21WAF1/Cip1-Cdk4-Cyclin D1 Assembly Circ. Res., July 20, 2007; 101(2): 146 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tu, W. Wu, T. Wu, Z. Cao, R. Wilkins, B.-H. Toh, M. E. Cooper, and Z. Chai Antiproliferative Autoantigen CDA1 Transcriptionally Up-regulates p21Waf1/Cip1 by Activating p53 and MEK/ERK1/2 MAPK Pathways J. Biol. Chem., April 20, 2007; 282(16): 11722 - 11731. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bockstaele, H. Kooken, F. Libert, S. Paternot, J. E. Dumont, Y. de Launoit, P. P. Roger, and K. Coulonval Regulated Activating Thr172 Phosphorylation of Cyclin-Dependent Kinase 4(CDK4): Its Relationship with Cyclins and CDK "Inhibitors". Mol. Cell. Biol., July 1, 2006; 26(13): 5070 - 5085. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moustakas and C.-H. Heldin Non-Smad TGF-{beta} signals J. Cell Sci., August 15, 2005; 118(16): 3573 - 3584. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gao, D. C. Flynn, Z. Zhang, X.-S. Zhong, V. Walker, K. J. Liu, X. Shi, and B.-H. Jiang G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells Am J Physiol Cell Physiol, August 1, 2004; 287(2): C281 - C291. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yu, X.-W. Liu, and H.-R. C. Kim Platelet-derived Growth Factor (PDGF) Receptor-{alpha}-activated c-Jun NH2-terminal Kinase-1 Is Critical for PDGF-induced p21WAF1/CIP1 Promoter Activity Independent of p53 J. Biol. Chem., December 5, 2003; 278(49): 49582 - 49588. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dupont, M. Karas, and D. LeRoith The Cyclin-dependent Kinase Inhibitor p21CIP/WAF Is a Positive Regulator of Insulin-like Growth Factor I-induced Cell Proliferation in MCF-7 Human Breast Cancer Cells J. Biol. Chem., September 26, 2003; 278(39): 37256 - 37264. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Kakonen, K. S. Selander, J. M. Chirgwin, J. J. Yin, S. Burns, W. A. Rankin, B. G. Grubbs, M. Dallas, Y. Cui, and T. A. Guise Transforming Growth Factor-beta Stimulates Parathyroid Hormone-related Protein and Osteolytic Metastases via Smad and Mitogen-activated Protein Kinase Signaling Pathways J. Biol. Chem., June 28, 2002; 277(27): 24571 - 24578. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Olashaw and W. J. Pledger Paradigms of Growth Control: Relation to Cdk Activation Sci. Signal., May 28, 2002; 2002(134): re7 - re7. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Jackson, A. DeLoose, and K. M. Gilbert Induction of Anergy in Th1 Cells Associated with Increased Levels of Cyclin-Dependent Kinase Inhibitors p21Cip1 and p27Kip1 1 J. Immunol., January 15, 2001; 166(2): 952 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yue and K. M. Mulder Requirement of Ras/MAPK Pathway Activation by Transforming Growth Factor beta for Transforming Growth Factor beta 1 Production in a Smad-dependent Pathway J. Biol. Chem., September 29, 2000; 275(40): 30765 - 30773. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pardali, A. Kurisaki, A. Moren, P. ten Dijke, D. Kardassis, and A. Moustakas Role of Smad Proteins and Transcription Factor Sp1 in p21Waf1/Cip1 Regulation by Transforming Growth Factor-beta J. Biol. Chem., September 15, 2000; 275(38): 29244 - 29256. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |